Cardiovascular Research

Do antioxidant vitamins reduce infarct size following acute myocardial ischemia/reperfusion?

Authors: S D Bellows|||S L Hale|||B Z Simkhovich|||G L Kay|||R A Kloner

Affiliations: + Expand

Abstract

There is controversy concerning the ability of antioxidant vitamins to reduce myocardial infarct size. We sought to determine whether a brief prophylactic treatment of vitamin C or vitamin C plus Trolox (a water-soluble form of vitamin E) could reduce myocardial infarct size in an experimental model. We used an anesthetized open-chest rabbit model in which a branch of the circumflex coronary artery was ligated for 30 minutes followed by 4 hours of reperfusion. Experiments were performed in a randomized and blinded fashion. An IV injection of normal saline pH balanced to 7.4 (control group n = 15), vitamin C (150 mg/kg, n = 14), or vitamin C plus Trolox (150 mg/kg plus 100 mg/kg, respectively, n = 15) was administered prior to coronary occlusion. Collateral blood flow during coronary occlusion was measured by radioactive microspheres, myocardial risk zone (AR) was assessed by blue dye injection, and myocardial infarct size (AN) was assessed by triphenyltetrazolium chloride staining. All rabbits received comparable ischemic insult: Collateral blood flow and AR were similar among all three groups. Infarct size, measured as a percent of AR, did not differ significantly among the controls (21%), vitamin C (29%), or the vitamin C plus Trolox (18%) groups. Therefore, in this ischemia/reperfusion model, antioxidant vitamins did not alter myocardial infarct size.

---

Chemical List

Antioxidants|||Chromans|||Free Radical Scavengers|||Tetrazolium Salts|||Vitamin E|||triphenyltetrazolium|||Ascorbic Acid|||6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

---

Reference List

Clin Cardiol. 1993 Apr;16(4 Suppl 1):I6-9|||N Engl J Med. 1993 May 20;328(20):1444-9|||Nature. 1979 Apr 19;278(5706):737-8|||N Engl J Med. 1993 May 20;328(20):1487-9|||J Mol Cell Cardiol. 1993 Jan;25(1):103-12|||Ann Neurol. 1992;32 Suppl:S28-32|||Artery. 1993;20(2):61-94|||Cardiovasc Res. 1989 Apr;23(4):323-30|||J Mol Cell Cardiol. 1988 Jan;20(1):35-45|||Lipids. 1990 Apr;25(4):199-210|||Cardiovasc Res. 1993 May;27(5):720-7|||Circulation. 1991 Sep;84(3):1420-5|||Am Heart J. 1989 Oct;118(4):667-73|||J Cardiovasc Pharmacol. 1991 May;17(5):761-7|||FEBS Lett. 1993 Oct 18;332(3):287-90|||Am J Physiol. 1989 May;256(5 Pt 2):H1344-52|||Can J Cardiol. 1993 Jan-Feb;9(1):94-8|||Basic Res Cardiol. 1991 Mar-Apr;86(2):127-35|||Ann Thorac Surg. 1989 Apr;47(4):553-7|||J Am Coll Cardiol. 1993 Feb;21(2):537-45|||Cardiovasc Res. 1993 Dec;27(12):2140-5|||Basic Res Cardiol. 1991 Jan-Feb;86(1):32-9|||J Clin Invest. 1993 Aug;92(2):1025-41|||Eur J Pharmacol. 1992 Jan 7;210(1):85-90|||FEBS Lett. 1990 Jul 2;267(1):29-32|||Arch Biochem Biophys. 1990 Nov 1;282(2):221-5|||Circulation. 1991 Oct;84(4):1758-72|||N Engl J Med. 1993 May 20;328(20):1450-6|||Biochem Pharmacol. 1993 May 25;45(10):1967-72|||J Lipid Res. 1992 Mar;33(3):385-97|||J Biol Chem. 1993 Sep 5;268(25):18532-41|||J Clin Invest. 1988 Aug;82(2):476-85|||Basic Res Cardiol. 1993 May-Jun;88(3):212-22|||Circ Res. 1986 Jan;58(1):148-56